| 产品描述: | THRX-144644 is a Lung-restricted ALK5 inhibitor with an IC50 value of 0.14 nM. THRX-144644 avoids systemic toxicities associated with TGFβ pathway inhibition. |
| 靶点: |
ALK5:0.14 nM (IC50) |
| 体外研究: |
THRX-144644 (2-60 mg/kg; Inhalation: nebulizer, daily, for 14 days) is a Lung-selective inhibitor and targets to the lungs in Sprague Dawley rats[1]. |
| 体内研究: |
THRX-144644 (1-10000 nM; 1 h) inhibits ALK5 with an IC50 value of 23 nM in human BEAS2B cell line. |
| 保存条件: |
-80°C 6个月; -20°C 1个月,避光,氮气保存 |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
1.953 ml |
9.766 ml |
19.531 ml |
| 5 mM |
0.391 ml |
1.953 ml |
3.906 ml |
| 10 mM |
0.195 ml |
0.977 ml |
1.953 ml |
| 50 mM |
0.039 ml |
0.195 ml |
0.391 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |